CWM
TERN

CIBC World Markets’s Terns Pharmaceuticals TERN Stock Holding History

CIBC World Markets’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$229K Buy
+5,674
New +$131K ﹤0.01% 1062
2025
Q2 		– Sell
-15,599
Closed -$43.1K – 1904
2025
Q1 		$43.1K Buy
+15,599
New +$63.7K ﹤0.01% 1731

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return

CIBC World Markets's TERN Position: Q4 2025 in Review

CIBC World Markets opened a new position in Terns Pharmaceuticals (TERN) in Q4 2025: 5,674 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #1062 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in TERN as recently as Q1 2025.

CIBC World Markets first reported a position in TERN in Q1 2025 and has held it in 2 quarters since. 248 funds tracked by Wall St. Rank hold TERN as of Q4 2025.

  • CIBC World Markets held 5,674 shares of Terns Pharmaceuticals worth $229K as of Q4 2025.
  • Terns Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Terns Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1062 holding.
  • CIBC World Markets first reported a position in Terns Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 248 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.